Carlos A. Zarate, MD: Modulators of the Glutamatergic System: Implications for the Development of Improved Therapeutics in Mood Disorders

Name: Carlos A. Zarate, MD: Modulators of the Glutamatergic System: Implications for the Development of Improved Therapeutics in Mood Disorders
SKU: 3053
Availability: InStock

$30.00

Want a discount? Become a member by purchasing Psychopharmacology Bulletin Subscription - Individual!

Categories: Psychopharmacology Bulletin, VOL 36 No. 4 Articles Tags: antidepressant, bipolar-disorder, carlos-a-zarate, depression, felbamate, glutamate, husseini-k-manji, jennifer-payne, jorge-quiroz, medworks-media, memantine, mood-stabilizer, nmdaampakainate, psychopharmacology-bulletin, riluzole

Description

Carlos A. Zarate, MD: Modulators of the Glutamatergic System: Implications for the Development of Improved Therapeutics in Mood Disorders

Description

Carlos A. Zarate, MD

TRANSLATIONAL NEUROSCIENCE

Modulators of the Glutamatergic System: Implications for the Development of Improved Therapeutics in Mood Disorders

Carlos A. Zarate, MD, Jorge Quiroz, MD, Jennifer Payne, MD, and Husseini K. Manji, MD

Antipsychotics Case Study by Yuan-Hwa Chou

Quetiapine XR Negative Clinical Trials Report by Gang Wang

Assessment of Anxiety in Clinical Trials with Depressed Patients

Clozapine Related Suicidal Obsession by Branka Aukst-Margetic

Carlos A. Zarate, MD: Modulators of the Glutamatergic System: Implications for the Development of Improved Therapeutics in Mood Disorders

Description

Carlos A. Zarate, MD

TRANSLATIONAL NEUROSCIENCE

Modulators of the Glutamatergic System: Implications for the Development of Improved Therapeutics in Mood Disorders

Carlos A. Zarate, MD, Jorge Quiroz, MD, Jennifer Payne, MD, and Husseini K. Manji, MD

Related products

Antipsychotics Case Study by Yuan-Hwa Chou

Quetiapine XR Negative Clinical Trials Report by Gang Wang

Assessment of Anxiety in Clinical Trials with Depressed Patients

Clozapine Related Suicidal Obsession by Branka Aukst-Margetic